XPeng Stock Forecast, Price Target & Analyst Ratings
Median price target
The median of the latest 12-month price targets from 7 Wall Street analysts on XPeng (XPEV), as of November 2026, against the last close of $9.37.
How we calculate these numbers
Median of each firm’s most recent 12-month price target published in the last 3 months (7 firms). Last close $9.37 on Nov 12, 2026. Each target comes from an analyst note listed on this page. Report an error
- Range
- $10 JP Morgan → $22 Freedom Broker
- Average
- $16.29 of the same 7 targets
- Ratings · last 3 months
- 7 of 12 analysts rate it Buy · 4 Hold · 1 Sell
XPeng share price and 12-month targets
The candles show the share price. The dotted lines run from today’s price to the highest, median and lowest 12-month analyst targets.
Where each firm stands on XPeng 17
Each firm’s latest rating and 12-month target, the upside from the last close, and how often its year-old targets were reached. Greyed targets are older than 3 months and stay out of the median.
 JP Morgan | Neutral | $10 ▼ from $11.50 | +7% | Oct 26, 2026 | 64% hit rate · 28 targets |
|---|---|---|---|---|---|
 CLSA | Outperform | No target | — | Oct 23, 2026 | — |
 Goldman Sachs | Buy | $16 ▼ from $18 | +71% | Oct 23, 2026 | 78% hit rate · 37 targets |
 Morgan Stanley | Overweight | $34 | +263% | Sep 15, 2026 older | 81% hit rate · 52 targets |
 UBS | Neutral | HK$47 | — | Sep 9, 2026 older | 81% hit rate · 54 targets |
 Citi | Buy | $22.50 ▼ from $25.60 | +140% | Aug 26, 2026 older | 88% hit rate · 43 targets |
 Freedom Broker | Buy | $22 ▼ from $25 | +135% | Aug 25, 2026 | — |
 Barclays | Underweight | $14 ▼ from $15 | +49% | Aug 25, 2026 | 83% hit rate · 40 targets |
 Bank of America | Buy | $19 | +103% | Aug 25, 2026 | 75% hit rate · 57 targets |
 Macquarie | Outperform | HK$73 | — | Aug 24, 2026 older | — |
 Bernstein | Market Perform | $18 ▼ from $20 | +92% | Aug 24, 2026 | 80% hit rate · 25 targets |
 US Tiger Securities | Hold | $15 ▼ from $20 | +60% | Aug 24, 2026 | — |
 Jefferies | Buy | $25.20 ▼ from $26.50 | +169% | May 29, 2026 older | 62% hit rate · 21 targets |
 BNP Paribas | Underperform | No target | — | Apr 22, 2026 | — |
 Nomura/Instinet | Buy | No target | — | Mar 23, 2026 | — |
 HSBC | Buy | $27.70 ▼ from $28.60 | +196% | Jan 20, 2026 older | 60% hit rate · 20 targets |
 Daiwa Securities | Buy | $29 ▲ from $24 | +209% | Nov 19, 2025 older | — |
AllLatest XPeng notes 57
Every research note on XPeng, newest first. Open one to read the analyst’s own words.
CitiBuyKept rating and price targetReiterated Aug 26HK$83.60maintainedJP MorganBuyUpgraded Aug 26HK$94Freedom BrokerBuyCut price target −12%, kept ratingCut target Aug 25$22from $25−12%JP MorganBuyCut price target −11%, kept ratingCut target Aug 25$24from $27−11%Goldman SachsBuyKept rating and price targetReiterated Aug 25HK$69maintainedBarclaysSellCut price target −7%, kept ratingCut target Aug 25$14from $15−7%Bank of AmericaBuyKept rating and price targetReiterated Aug 25$19maintainedMacquarieBuyKept rating and price targetReiterated Aug 24HK$70maintainedBernsteinHoldCut price target −10%, kept ratingCut target Aug 24$18from $20−10%US Tiger SecuritiesHoldCut price target −25%, kept ratingCut target Aug 24$15from $20−25%Goldman SachsBuyCut price target −13%, kept ratingCut target Aug 3$20from $23−13%How the target has moved
Median targetShare priceSince the end of November 2025, the median 12-month price target on XPeng has fallen 41%, from $27 to $16, while the share price has lost 57%. Buy ratings went from 50% to 58% of the firms covering the stock.
Month-by-month data and method
| Date | Median target | Firms | Buy | Share price |
|---|---|---|---|---|
| Today | $16 | 7 | 58% | $9.37 |
| Oct 31, 2026 | $16 | 7 | 58% | $9.04 |
| Sep 30, 2026 | $18 | 7 | 55% | $9.56 |
| Aug 31, 2026 | $19 | 7 | 67% | $11.36 |
| Jul 31, 2026 | $23.75 | 6 | 83% | $13.00 |
| Jun 30, 2026 | $23.75 | 6 | 71% | $13.24 |
| May 31, 2026 | $22.50 | 9 | 67% | $16.45 |
| Apr 30, 2026 | $22 | 7 | 50% | $16.30 |
| Mar 31, 2026 | $22 | 9 | 64% | $17.11 |
| Feb 28, 2026 | $26 | 7 | 88% | $17.56 |
| Jan 31, 2026 | $26 | 7 | 71% | $17.98 |
| Dec 31, 2025 | $27 | 4 | 50% | $20.28 |
| Nov 30, 2025 | $27 | 4 | 50% | $21.83 |
Each point is the median of every firm’s most recent 12-month target published in the three months before that date, the same rule as the headline median. Month-end points, plus today. Prices and targets are split-adjusted.
Earnings reactions
How Wall Street moved its price targets right after each of XPeng’s last 2 reports. Latest: Aug 24 · All companies
XPeng stock forecast: questions
What is the price target for XPeng stock?
As of November 2026, the median 12-month price target on XPeng (XPEV) is $16, based on the latest target from each of 7 Wall Street analysts in the last 3 months. That is 71% above the latest price of $9.37.
What is the XPeng stock forecast for 2027?
Wall Street’s 12-month price targets on XPeng (XPEV) look ahead to August to October 2027. The median of the 7 latest targets is $16, 71% above the latest price, and they range from $10 to $22. A price target is an analyst’s estimate, not a promise.
Can XPeng stock reach $22?
Freedom Broker has the highest 12-month price target on XPeng, $22, 135% above the latest price of $9.37. At least half of the 7 analysts have a target at or below the median of $16.
What are the highest and lowest XPeng price targets?
The highest 12-month target is $22 from Freedom Broker and the lowest is $10 from JP Morgan.
Is XPeng a Buy, Hold or Sell?
Over the last 3 months, 12 Wall Street analysts rate XPeng: 7 Buy, 4 Hold and 1 Sell.
Why the median and not the average?
The median is the middle target, so one very high or very low call does not move it. The average of the same 7 targets is $16.29.